Meiosis-specific nuclear structural protein 1 (MNS1)

Meiosis-specific nuclear structural protein 1 (MNS1) is a multifunctional, coiled-coil protein that plays an essential structural role in meiosis and spermatogenesis. It is highly expressed at the pachytene stage during spermatogenesis and is required for proper nuclear morphology in meiotic cells, acting as a nuclear skeletal protein[1][2][4]. In addition to its nuclear functions, MNS1 is crucial for the organization of motile cilia and sperm flagella, localizing along the axonemes and facilitating assembly of the outer dynein arm docking complex via interactions with structural axonemal proteins. Inactivation results in male infertility due to abnormal flagellar architecture and motility, and systemic disruptions such as laterality defects (resulting from nodal cilia malfunction), as well as respiratory issues[1][3]. Recent studies suggest MNS1 may play an oncogenic role in hepatocellular carcinoma by activating oncogenic PI3K/AKT signaling[5][6]. Despite its structural and developmental importance, MNS1 is not recognized as a conventional therapeutic target (e.g., enzyme or receptor), and there are no established drugs or biomarker applications involving direct modulation of this protein.

Other names

SPATA40FLJ11222HTX9spermatogenesis associated 40